Papers - KADOMATSU, Kenji
-
Relation between human decay-accelerating factor (hDAF) expression in pig cells and inhibition of human serum anti-pig cytotoxicity: value of highly expressed hDAF for Xenotransplantation. Reviewed
Liu, D., Kobayashi, T., Onishi, A., Furusawa, T., Iwamoto, M., Suzuki, S., Miwa, Y., Nagasaka, T., Maruyama, S., Kadomatsu, K., Uchida, K., Nakao, A.
Xenotransplantation Vol. 14 ( 1 ) page： 67-73 2007.1
-
Paeonol attenuates TNBS-induced colitis by inhibiting NF-kappaB and STAT1 transactivation. Reviewed
Ishiguro K, Ando T, Maeda O, Hasegawa M, Kadomatsu K, Ohmiya N, Niwa Y, Xavier R, Goto H.
Toxicol. Appl. Pharmacol. Vol. 217 ( 1 ) page： 35-42 2006.11
-
Brain keratan sulfate and glial scar formation. Reviewed
Zhang, H., Uchimura, K., Kadomatsu, K.
Ann. NY Acad. Sci. Vol. 1086 page： 81-90 2006.11
-
Midkine plays a protective role against cardiac ischemia /reperfusion Injury through a reduction of apoptotic reaction. Reviewed
Horiba M, Kadomatsu K, Uasui K, Lee J, Takenaka H, Sumida A, Kamiya K, Chen S, Sakuma S, Muramatsu T, Komada I.
Circulation Vol. 114 ( 16 ) page： 1713-1720 2006.10
-
Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts. Reviewed
Banno H, Takei Y, Muramatsu T, Komori K, Kadomatsu K.
J. Vas. Surg. Vol. 44 ( 3 ) page： 633-641 2006.9
-
Combinational antitumor effect of siRNA against midkine and paclitaxel on growth of human prostate cancer xenografts. Reviewed
Takei Y, Kadomatsu K, Goto T, Muramatsu T.
Cancer Vol. 107 ( 4 ) page： 864-873 2006.8
-
N-Acetylglucosamine 6-O-sulfotransferase-1 is required for brain keratan sulfate biosynthesis and glial scar formation after brain injury. Reviewed
Zhang H, Muramatsu T, Murase A, Yuasa S, Uchimura K, Kadomatsu K.
Glycobiology Vol. 16 ( 8 ) page： 702-710 2006.8
-
Loss of core fucosylation of low-density lipoprotein receptor-related protein-1 impairs its function, leading to the upregulation of serum levels of insulin-like growth factor-binding protein 3 in Fut8-/- mice. Reviewed
Lee SH, Takahashi M, Honke K, Miyoshi E, Osumi D, Sakiyama H, Ekuni A, Wang X, Inoue S, Gu J, Kadomatsu K, Taniguchi N.
J. Biochem. Vol. 139 ( 3 ) page： 391-398 2006.3
-
Growth factor midkine is involved in the pathogenesis of diabetic nephropathy. Reviewed
Kosugi T, Yuzawa Y, Sato W, Kawai H, Matsuo S, Takei Y, Muramatsu T, Kadomatsu K.
Am. J. Pathol. Vol. 168 ( 1 ) page： 9-19 2006.1
-
Putative midkine family protein up-regulation in Patella caerulea (Mollusca, Gastropoda) exposed to sublethal concentrations of cadmium. Reviewed
Vanucci S, Minerdi D, Kadomatsu K, Mengoni A, Bazzicalupo M.
Aquat. Toxicol. Vol. 75 ( 4 ) page： 374-379 2005.11
-
N-Acetylglucosamine-6-O-sulfotransferase-1 and -2 cooperatively control lymphocyte homing through L-selectin ligand biosynthesis in high endothelial venules. Reviewed
Kawashima, H., Petryniak, B., Hiraoka, N., Mitoma, J., Huckaby, V., Nakayama, J., Uchimura, K. Kadomatsu, K., Muramatsu, T., Lowe, J.B., Fukuda, M.
Nat. Immunol. Vol. 6 ( 11 ) page： 1096-1104 2005.11
-
The midkine family in cancer, inflammation and neural development. Reviewed
Kadomatsu, K.
Nagoya J. Med. Sci. Vol. 67 ( 3-4 ) page： 71-82 2005.6
-
Antisense oligodeoxyribonucleotide as to the growth factor midkine suppresses neointima formation induced by balloon Injury. Reviewed
Hayashi, K., Banno, H., Kadomatsu, K.*, Takei, Y., Komori, K., Muramatsu, T.
Am. J. Physiol. Heart Circ. Physiol. Vol. 288 ( 5 ) page： 2203-2209 2005.5
-
Morpholino antisense oligomer targeting human midikine: its application for cancer therapy. Reviewed
Takei, Y., Kadomatsu, K., Yuasa, K., Sato, W., Muramatsu, T.
Int. J. Cancer Vol. 114 ( 3 ) page： 490-497 2005.4
-
Midkine antisense oligodeoxyribonucleotide inhibits renal damage induced by ischemic reperfusion. Reviewed
Sato, W., Takei, Y., Yuzawa,Y., Matsuo, S., Kadomatsu, K., Muramatsu, T.
Kidney Int. Vol. 67 ( 4 ) page： 1330-1339 2005.4
-
Postischemic gene transfer of midkine, a neurotrophic factor, protects against focal brain ischemia. Reviewed
Takada, J., Ooboshi, H., Ago, T., Kitazono, T., Yao, H., Kadomatsu, K., Muramatsu, T., Ibayashi, S., Iida, M.
Gene Ther. Vol. 12 ( 6 ) page： 487-493 2005.3
-
In vivo delivery technique of nucleic acid compounds using atelocollagen: its use in cancer therapeutics targeted at the heparin-binding growth factor midkine. Invited
Takei, Y., Kadomatsu, K.
Gene Ther. Mol. Biol. Vol. 9 page： 257-264 2005
-
Midkine expression in rat spinal motor neurons following sciatic nerve injury. Reviewed
Sakakima, H., Yoshida, Y., Kadomatsu, K., Yuzawa, Y., Matsuo, S., Muramatsu, T.
Brain Res. Dev. Brain Res. Vol. 153 ( 2 ) page： 251-260 2004.11
-
Effects of flanking genes on the phenotypes of mice deficient in basigin/CD147. Reviewed
Chen, S., Kadomatsu, K., Kondo, M., Toyama, Y., Toshimori, K., Ueno, S., Miyake, Y., Muramatsu, T.
Biochem. Biophys. Res. Commun. Vol. 324 ( 1 ) page： 147-153 2004.11
-
Lack of the growth factor midkine enhances survival against cisplatin-induced renal damage. Reviewed
Kawai, H., Sato, W., Yuzawa, Y., Kosugi, T., Matsuo, S., Takei, Y., Kadomatsu, K., Muramatsu, T.
Am. J. Pathol. Vol. 165 ( 5 ) page： 1603-1612 2004.11